.

Chemocentryx reported $419.39M in Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Alnylam Pharmaceuticals ALNY:US $ 3330.42M 103.13M
Amgen AMGN:US $ 59294M 98M
AstraZeneca AZN:LN 7932612.74M 297425.43M
Bayer BAYN:GR € 128794M 3012M
Biogen BIIB:US $ 25081.4M 1467M
Biomarin Pharmaceutical BMRN:US $ 6145.84M 83.13M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Chemocentryx CCXI:US $ 419.39M 21.06M
GlaxoSmithKline GSK:LN 8904500M 64400M
Glaxosmithkline GSK:US $ 89045M 644M
Macrogenics MGNX:US $ 218.04M 53.4M
Mirati Therapeutics MRTX:US $ 1279.79M 141.51M
Novartis NOVN:VX SF 122910M 2308M
Omeros OMER:US $ 345.64M 23.62M
Sarepta Therapeutics SRPT:US $ 2996.85M 59.3M
Takeda 4502:JP Y 14065426M 887408M
Teva Pharmaceutical TEVA:IT 45.93B 1.13B
YTE INCY:US $ 5319.04M 264.81M